Pharmafile Logo

Clinical trial considerations: Why digital matters…

February 14, 2024 | Digital, clinical trials, technology 

Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.

There is no doubt we live in a digital world. We use tech every day of our lives, including when it comes to our health. Wearable devices to track your daily steps, smartphone apps to help you quit smoking, or virtual meetings to attend GP appointments remotely. Digital technology in healthcare is rapidly evolving and enabling new solutions for patients.

With all this being said, it is no surprise that pharma companies are turning to digital solutions to help improve the patient experience within clinical trials. Virtual study visits make it easier for patients to attend appointments, whilst mobile devices and at-home monitoring systems can help collect real-time data. Here are some of the things that are front of mind when we support our clients navigate new digital strategies for clinical trials.

Device compatibility

Patients are increasingly using mobile devices as their primary source of information. However, HCPs will generally use desktops or laptops in a clinic or office. Make sure to think about who you are creating digital materials for and how content will be accessed and used.

The best user experience for all

How does your content fit with the channel you are using to deliver it? In some instances, simply providing PDF versions of printed materials may be sufficient. But could there be other ways of utilising digital formats to make the content easier to understand or more accessible for patients? Audio, videos or animations are engaging and can help to simplify complex information. Web pages can provide accessibility features, such as a screen reader and size adjustment to help people with visual impairments access the information they need.

Embracing personalisation

Personal touches help people to feel valued, such as using a participant’s name or understanding their preferences or cultural nuances. Each person’s experience will be different so we should also consider how we can personalise the care that is offered. One way we’ve supported this is through symptom trackers, providing personalised care tips to help each patient deal with their side effects at home. Individualising content helps patients to feel valued, and not just a statistic.

Increasing interactivity

A great way to improve engagement and retention in clinical trials is to increase interactivity. For example, we’ve used appointment reminders, medication notifications, and emails thanking participants for their continued participation. We’ve also been exploring ways to bring in interactivity earlier in the process — be it a QR code on a trial advert or bringing informed consent to life with animations and pop-ups to help explain complex elements.

Encouraging action

Content delivered in digital form can include direct calls to action that motivate patients to find out more or take the first step in joining a trial by reaching out to get in touch. Links can send patients instantly to other relevant content or help them access relevant forms to find out if they are a good candidate to join a trial.

Sustainability

Taking action to improve sustainability is fundamental for the health of the planet. Unfortunately, clinical trials can be big contributors to greenhouse gas emissions, but digitalising trials can help improve their sustainability whilst still keeping patient’s needs a priority. At-home tests and assessments, and virtual appointments decrease the need for travel. And providing patients with all the necessary information straight to their mobile phones reduces the need for large print runs and limits potential waste.

At Cuttsy+Cuttsy, we’ve developed materials and tools in all sorts of formats to help deliver successful clinical trials. If you’d like to discuss how digital can complement your next trial programme, let’s talk.

You can read all our latest clinical trials explained blogs here.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Does being an independent agency really matter?

With Cuttsy+Cuttsy ranked as #6 in the Independent Agencies listing from PM Live’s T40 Creative Healthcare Agencies 2021, Mathew Cutts reflects on what being ‘independent’ means to him.

Opening up about patient engagement

Read the third blog of the series looking at key barriers to effective patient engagement in pharma

Committing time to making meaningful connections – top 5 tips

Read the second blog of the series looking at key barriers to effective patient engagement in pharma

Key barriers to effective patient engagement in pharma, and how to fix them: Making engagement processes more patient friendly

In the first of this blog series, Patient Engagement Lead, Philippa Pristerà looks at making engagement processes more patient friendly

Cuttsy+Cuttsy awarded Gold accreditation by Investors in People

Healthcare communications agency, Cuttsy+Cuttsy, has been awarded ‘We invest in People, Gold’ from Investors in People.

Cuttsy+Cuttsy marks its 10th anniversary with the launch of Cuttsy Cares

Healthcare communications agency, Cuttsy+Cuttsy, has announced the launch of Cuttsy Cares, in celebration of its 10th anniversary.  The agency's charitable programme will deliver up to £10,000 to help improve the quality...

Caroline Benson and Colin Williams to Chair the PM Society from February 2020

For the first time both industry and agencies will be equally represented as the PM Society appoints a joint chair.

Clinical trials, Actually.

This Christmas, we’re thinking of the thousands of clinical trial volunteers across the UK, both patients and healthy participants. We have a lot to thank them for...

A patient view on the ABPI’s patient collaboration sourcebook

Last month, the ABPI released a much-in-demand document: The Working with Patients and Patient Organisations sourcebook.

The Exhibition Hall: Past, Present and Future

As I sit here at another pharma conference, I start to reflect on how they have changed over the years.